Literature DB >> 32289216

Drug Evaluation during the Covid-19 Pandemic.

Benjamin N Rome1, Jerry Avorn1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32289216     DOI: 10.1056/NEJMp2009457

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  48 in total

1. 

Authors:  Peter J Zed
Journal:  Can J Hosp Pharm       Date:  2020-06-01

2.  Pharmacy Leadership during the COVID-19 Pandemic.

Authors:  Peter J Zed
Journal:  Can J Hosp Pharm       Date:  2020-06-01

3.  A Nucleocapsid-based Transcomplementation Cell Culture System of SARS-CoV-2 to Recapitulate the Complete Viral Life Cycle.

Authors:  Yanying Yu; Xiaohui Ju; Qiang Ding
Journal:  Bio Protoc       Date:  2021-11-05

4.  Off-Label Drug Use in Pediatric Out-Patient Care: A Multi-Center Observational Study.

Authors:  Aeshah AlAzmi; Zahra Alasmari; Consuela Yousef; Ahmed Alenazi; Mohammed AlOtaibi; Hani AlSaedi; Adnan AlShaikh; Amani AlObathani; Omaima Ahmed; Loie Goronfolah; Mousa Alahmari
Journal:  Hosp Pharm       Date:  2020-08-31

5.  Pharmacy Leadership Amid the Pandemic: Maintaining Patient Safety During Uncertain Times.

Authors:  Irene Derrong Lin; John B Hertig
Journal:  Hosp Pharm       Date:  2021-08-05

6.  COVID-19 Pandemic and the Burden of Acute Kidney Injury: The Known and the Unknown.

Authors:  Talha H Imam
Journal:  Perm J       Date:  2020-12

Review 7.  Severity and Mortality Associated with Steroid Use among Patients with COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Tamiru Sahilu; Tadesse Sheleme; Tsegaye Melaku
Journal:  Interdiscip Perspect Infect Dis       Date:  2021-05-06

8.  COVID-19 pandemic response varies by clinical trial sponsor type.

Authors:  Lisa Cooper; Irene Lee; Doreen Waldron Lechner
Journal:  J Clin Transl Sci       Date:  2021-03-16

9.  EA3: A softmax algorithm for evidence appraisal aggregation.

Authors:  Francesco De Pretis; Jürgen Landes
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

10.  Public perceptions of the role of government and nonstate actors in responding to COVID-19.

Authors:  Daniel Sledge; Herschel F Thomas
Journal:  Risk Hazards Crisis Public Policy       Date:  2021-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.